Soleno Therapeutics SLNO

$ 45.15 -0.11%

Quarterly report 2024-Q3
added 11-06-2024

Soleno Therapeutics EV/EBITDA Ratio 2011-2024 | SLNO

Annual EV/EBITDA Ratio Soleno Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.12	-3.56	-4.2	-1.1	0.183	-0.77	-0.592	1.2	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.2	-4.2	-1.09